+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infection & Infection POCT Testing Market - Global Forecast 2026-2032- Product Image
Infection & Infection POCT Testing Market - Global Forecast 2026-2032- Product Image
Sale

Infection & Infection POCT Testing Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6148593
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Infection & Infection POCT Testing Market is projected to reach USD 935.70 Million in 2026. It is expected to continue growing at a CAGR of 7.04%, reaching USD 1.40 Billion by 2032.

Infection and Infection POCT Testing: Executive Overview

Infection point-of-care testing (POCT) enables diagnostic decisions near the patient rather than exclusively in centralized laboratories. Its value is greatest where rapid identification of infectious conditions can support timely treatment, isolation, antimicrobial stewardship, and public-health response. Adoption is shaped by clinical utility, test accuracy, workflow integration, regulatory requirements, reimbursement, supply reliability, and the ability of healthcare systems to train users and manage results.

From Centralized Diagnosis to Distributed Clinical Decision-Making

The landscape is shifting toward decentralized testing across hospitals, primary-care settings, pharmacies, community programs, workplaces, and home environments. Multiplex assays, molecular platforms, antigen tests, and connected readers are broadening the range of infections that can be assessed near the patient. At the same time, buyers are placing greater emphasis on analytical validation, quality control, interoperability, ease of use, and responsible test utilization rather than speed alone. These shifts favor solutions that combine dependable performance with clear clinical pathways and strong post-market surveillance.

Artificial Intelligence Strengthens Interpretation, Triage, and Operations

Artificial intelligence can improve infection POCT by supporting image interpretation, result quality checks, symptom-based triage, workflow prioritization, and surveillance analytics. Its cumulative impact depends on representative training data, transparent validation, cybersecurity, privacy protection, and human oversight. AI should complement rather than replace qualified clinical judgment, particularly when results are discordant with symptoms or when false positives and false negatives carry substantial consequences. Systems that document model performance across populations and settings are better positioned for safe integration.

Regional Insights: Infrastructure and Access Determine Adoption

North America is characterized by established clinical infrastructure, expanding decentralized-care pathways, and close attention to reimbursement, compliance, and interoperability. Latin America presents opportunities linked to improved primary care and infectious-disease access, while uneven laboratory capacity, procurement constraints, and geographic dispersion remain important considerations. Europe emphasizes evidence, quality systems, antimicrobial stewardship, and cross-border health coordination. The Middle East is investing in modern healthcare delivery and centralized preparedness alongside varied regulatory environments. Africa’s priorities include affordability, rugged deployment, supply continuity, and community-based access. Asia-Pacific combines advanced health systems with large underserved populations, making localization, scalable distribution, and workforce training especially important.

Group Insights: Cooperation Shapes Standards and Deployment

ASEAN markets reflect diverse regulatory systems and healthcare capacities, increasing the value of interoperable platforms, regional procurement knowledge, and adaptable training. BRICS members span major differences in infrastructure, disease burden, and public-sector purchasing, so deployment models must accommodate both sophisticated facilities and resource-constrained settings. The European Union benefits from coordinated regulatory and public-health frameworks, although implementation remains dependent on national systems. G7 countries generally emphasize clinical evidence, cybersecurity, stewardship, and integration with mature care networks. GCC countries combine centralized health planning with strong interest in advanced diagnostics and preparedness. NATO members place particular importance on resilience, continuity of supply, emergency readiness, and interoperability across civil and defense-related health structures.

Country Insights: National Priorities Create Distinct Testing Pathways

Australia’s geographically dispersed care model supports decentralized testing when logistics and connectivity are reliable. Brazil’s scale and regional variation make affordability, public-system integration, and distribution central issues. Canada must address distance, rural access, and coordination across healthcare jurisdictions. China combines extensive manufacturing and digital-health capabilities with the need for consistent quality and broad access. France, Germany, Italy, and Spain operate within European quality and regulatory expectations while retaining distinct reimbursement and care-delivery structures. India’s large population and varied infrastructure favor low-complexity, scalable testing linked to primary care. Japan emphasizes reliability, aging-population needs, and workflow precision. Mexico faces uneven access and the importance of strengthening frontline diagnostic capacity. Russia’s priorities include domestic resilience and geographically broad service delivery. South Korea is notable for technology-enabled healthcare and preparedness requirements. The United Kingdom emphasizes evidence, stewardship, and integration across publicly funded care pathways. The United States combines advanced diagnostics with complex reimbursement, regulatory, and provider purchasing environments.

Priorities for Leaders: Build Trustworthy, Connected, and Accessible Testing

Industry leaders should prioritize assays with demonstrated clinical utility, transparent performance claims, and simple workflows suited to the intended setting. They should design interoperability from the outset so results can flow securely into electronic records, surveillance systems, and antimicrobial-stewardship programs. Portfolio planning should address affordability, resilient sourcing, local service support, training, quality assurance, and responsible disposal. AI-enabled features require documented validation, bias monitoring, explainability, cybersecurity controls, and clear escalation to clinicians. Partnerships with health systems and public-health authorities can clarify care pathways, while post-market evidence should guide continuous improvement and responsible expansion into new populations.

Research Methodology: Evidence-Based Assessment of Infection POCT

The assessment uses a structured review of publicly available clinical, regulatory, policy, and health-system evidence relevant to infection and infection POCT testing. It considers technology types, use settings, workflow requirements, diagnostic performance, access conditions, reimbursement influences, data connectivity, and implementation barriers. Regional, group, and country perspectives are synthesized from documented healthcare infrastructure, preparedness priorities, regulatory approaches, and testing needs. Interpretations are limited to verifiable qualitative insights; no market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Clinical Utility and System Readiness Will Define Progress

Infection POCT is becoming an important component of distributed healthcare, but successful adoption requires more than rapid results. Reliable performance, appropriate clinical use, connected workflows, sustainable procurement, trained personnel, and equitable access must advance together. Regional and national differences will continue to shape deployment, while AI can add value when governed by strong evidence and human oversight. Leaders that align innovation with clinical pathways, public-health objectives, and operational resilience will be best placed to deliver measurable improvements in infection management.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Infection & Infection POCT Testing Market, by Product Type
7.1. Introduction
7.2. Instruments
7.3. Reagents & Kits
7.4. Software & Services
8. Infection & Infection POCT Testing Market, by Platform Technology
8.1. Introduction
8.2. Biosensor
8.2.1. Electrochemical
8.2.2. Optical
8.3. Immunoassay
8.3.1. Clia
8.3.2. Elisa
8.4. Lateral Flow Assay
8.5. Molecular Technique
8.5.1. Isothermal Amplification
8.5.2. Pcr
9. Infection & Infection POCT Testing Market, by Sample Type
9.1. Introduction
9.2. Saliva
9.3. Serum Or Plasma
9.4. Urine
9.5. Whole Blood
10. Infection & Infection POCT Testing Market, by Application
10.1. Introduction
10.2. Hepatitis
10.2.1. Hepatitis B
10.2.2. Hepatitis C
10.3. HIV
10.4. Influenza
11. Infection & Infection POCT Testing Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Home Care Settings
11.4. Hospitals & Clinics
12. Infection & Infection POCT Testing Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Infection & Infection POCT Testing Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Infection & Infection POCT Testing Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Accubiotech Co. Ltd.
16.3. ACON Laboratories Inc.
16.4. Becton, Dickinson and Company
16.5. Bio-Rad Laboratories Inc.
16.6. bioMérieux SA
16.7. Chembio Diagnostics Inc.
16.8. Credo Diagnostics Biomedical Pte Ltd.
16.9. Danaher Corporation
16.10. EKF Diagnostics Holdings plc
16.11. F. Hoffmann-La Roche Ltd
16.12. HemoCue AB
16.13. Johnson & Johnson
16.14. LumiraDx Limited
16.15. Meridian Bioscience Inc.
16.16. Nova Biomedical Corporation
16.17. Orasure Technologies Inc.
16.18. PTS Diagnostics
16.19. QIAGEN N.V.
16.20. QuidelOrtho Corporation
16.21. Sekisui Diagnostics LLC
16.22. Siemens Healthineers AG
16.23. Sysmex Corporation
16.24. Thermo Fisher Scientific Inc.
16.25. Trinity Biotech plc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Infection & Infection POCT Testing Market, Years Considered for the Study
FIGURE 2. Global Infection & Infection POCT Testing Market, Research Design
FIGURE 3. Global Infection & Infection POCT Testing Market, Research Framework
FIGURE 4. Global Infection & Infection POCT Testing Market, Data Triangulation
FIGURE 5. Global Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Infection & Infection POCT Testing Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Infection & Infection POCT Testing Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Infection & Infection POCT Testing Market Size, by Platform Technology, 2025 vs 2032 (%)
FIGURE 9. Global Infection & Infection POCT Testing Market Size, by Platform Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Infection & Infection POCT Testing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Infection & Infection POCT Testing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Infection & Infection POCT Testing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Infection & Infection POCT Testing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Infection & Infection POCT Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Infection & Infection POCT Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Infection & Infection POCT Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Infection & Infection POCT Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Infection & Infection POCT Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Infection & Infection POCT Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Infection & Infection POCT Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Infection & Infection POCT Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Infection & Infection POCT Testing Market Segmentation & Coverage
TABLE 2. Global Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Software & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Software & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Software & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 14. Global Biosensor Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Biosensor Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Biosensor Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Electrochemical Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Electrochemical Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Electrochemical Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Optical Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Optical Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Optical Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Clia Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Clia Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Clia Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Elisa Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Elisa Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Elisa Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Molecular Technique Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Molecular Technique Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Molecular Technique Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 45. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Serum Or Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Serum Or Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Serum Or Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Global Hepatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Hepatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Hepatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Hepatitis B Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Hepatitis B Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Hepatitis B Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Hepatitis C Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Hepatitis C Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Hepatitis C Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global HIV Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global HIV Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global HIV Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Influenza Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Influenza Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Influenza Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Home Care Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Home Care Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Home Care Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. North America Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. North America Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 96. North America Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 97. North America Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 98. North America Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 99. North America Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 100. North America Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 101. North America Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. North America Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 103. North America Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Latin America Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Latin America Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 106. Latin America Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 107. Latin America Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 108. Latin America Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 109. Latin America Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 110. Latin America Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 111. Latin America Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 112. Latin America Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 113. Latin America Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Europe Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Europe Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 116. Europe Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 117. Europe Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 118. Europe Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 119. Europe Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 120. Europe Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. Europe Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Europe Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 123. Europe Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Middle East Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Middle East Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 126. Middle East Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 127. Middle East Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 128. Middle East Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 129. Middle East Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 130. Middle East Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. Middle East Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Middle East Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 133. Middle East Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Africa Infection & Infection POCT Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Africa Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 136. Africa Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 137. Africa Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 138. Africa Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 139. Africa Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 140. Africa Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 141. Africa Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Africa Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 143. Africa Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Global Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. ASEAN Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. ASEAN Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 148. ASEAN Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 149. ASEAN Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 150. ASEAN Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 151. ASEAN Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 152. ASEAN Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. ASEAN Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 154. ASEAN Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. GCC Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. GCC Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 157. GCC Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 158. GCC Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 159. GCC Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 160. GCC Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 161. GCC Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 162. GCC Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 163. GCC Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 164. GCC Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. European Union Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. European Union Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 167. European Union Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 168. European Union Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 169. European Union Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 170. European Union Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 171. European Union Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 172. European Union Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 173. European Union Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 174. European Union Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. BRICS Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 176. BRICS Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. BRICS Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 178. BRICS Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 179. BRICS Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 180. BRICS Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 181. BRICS Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 182. BRICS Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. BRICS Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 184. BRICS Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. G7 Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. G7 Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 187. G7 Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 188. G7 Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 189. G7 Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 190. G7 Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 191. G7 Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 192. G7 Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. G7 Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 194. G7 Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. NATO Infection & Infection POCT Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 196. NATO Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 197. NATO Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 198. NATO Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 199. NATO Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 200. NATO Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 201. NATO Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 202. NATO Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. NATO Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 204. NATO Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. Global Infection & Infection POCT Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 206. United States Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 207. United States Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 208. United States Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 209. United States Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 210. United States Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 211. United States Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 212. United States Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 213. United States Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. United States Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 215. United States Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Canada Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 217. Canada Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 218. Canada Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 219. Canada Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 220. Canada Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 221. Canada Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 222. Canada Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 223. Canada Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Canada Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 225. Canada Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Mexico Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 227. Mexico Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. Mexico Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 229. Mexico Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 230. Mexico Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 231. Mexico Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 232. Mexico Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. Mexico Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Mexico Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 235. Mexico Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Brazil Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 237. Brazil Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. Brazil Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 239. Brazil Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 240. Brazil Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 241. Brazil Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 242. Brazil Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 243. Brazil Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Brazil Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 245. Brazil Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. United Kingdom Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 247. United Kingdom Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. United Kingdom Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 249. United Kingdom Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 250. United Kingdom Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 251. United Kingdom Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 252. United Kingdom Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 253. United Kingdom Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. United Kingdom Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 255. United Kingdom Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. Germany Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 257. Germany Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 258. Germany Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 259. Germany Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 260. Germany Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 261. Germany Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 262. Germany Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 263. Germany Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. Germany Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 265. Germany Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. France Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 267. France Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 268. France Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 269. France Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 270. France Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 271. France Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 272. France Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 273. France Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 274. France Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 275. France Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Russia Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 277. Russia Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 278. Russia Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 279. Russia Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 280. Russia Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 281. Russia Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 282. Russia Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 283. Russia Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. Russia Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 285. Russia Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Italy Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 287. Italy Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 288. Italy Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 289. Italy Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 290. Italy Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 291. Italy Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 292. Italy Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 293. Italy Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 294. Italy Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 295. Italy Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Spain Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 297. Spain Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. Spain Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 299. Spain Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 300. Spain Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 301. Spain Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 302. Spain Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 303. Spain Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 304. Spain Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 305. Spain Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. China Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 307. China Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 308. China Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 309. China Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 310. China Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 311. China Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 312. China Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 313. China Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. China Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 315. China Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. India Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 317. India Infection & Infection POCT Testing Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 318. India Infection & Infection POCT Testing Market Size, by Platform Technology, 2017-2032 (USD Million)
TABLE 319. India Infection & Infection POCT Testing Market Size, by Biosensor, 2017-2032 (USD Million)
TABLE 320. India Infection & Infection POCT Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 321. India Infection & Infection POCT Testing Market Size, by Molecular Technique, 2017-2032 (USD Million)
TABLE 322. India Infection & Infection POCT Testing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 323. India Infection & Infection POCT Testing Market Size, by Application, 2017-2032 (USD Million)
TABLE 324. India Infection & Infection POCT Testing Market Size, by Hepatitis, 2017-2032 (USD Million)
TABLE 325. India Infection & Infection POCT Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Japan Infection & Infection POCT Testing Market Size, 2017-2032 (USD Million)
TABLE 327. Japan Infection & Infection POCT Testing Market Size, by Product Type, 20

Companies Mentioned

  • Abbott Laboratories
  • Accubiotech Co. Ltd.
  • ACON Laboratories Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Chembio Diagnostics Inc.
  • Credo Diagnostics Biomedical Pte Ltd.
  • Danaher Corporation
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd
  • HemoCue AB
  • Johnson & Johnson
  • LumiraDx Limited
  • Meridian Bioscience Inc.
  • Nova Biomedical Corporation
  • Orasure Technologies Inc.
  • PTS Diagnostics
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Sekisui Diagnostics LLC
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech plc

Related Topics

Related Reports

Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2026-2032 - Product Image

Colloidal Gold Immunochromatographic Assay POCT Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
POCT Chemiluminescence Immunoassay Analyzer Market - Global Forecast 2026-2032 - Product Image

POCT Chemiluminescence Immunoassay Analyzer Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Point-of-Care-Testing (POCT) Market Report 2026 - Product Image

Point-of-Care-Testing (POCT) Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Blood Viscometer Market Size, Share & Trends Analysis Report by Product (Capillary Viscometers, Rotational Viscometers, Microfluidic Viscometers), Application (Clinical Diagnostics, Point-of-Care Testing (POCT), End Use and Region with Growth Forecasts, 2025-2033 - Product Image

Blood Viscometer Market Size, Share & Trends Analysis Report by Product (Capillary Viscometers, Rotational Viscometers, Microfluidic Viscometers), Application (Clinical Diagnostics, Point-of-Care Testing (POCT), End Use and Region with Growth Forecasts, 2025-2033

  • Report
  • 105 Pages
  • Global
From
2025 Global Forecast for Point-Of-Care (Poc) Testing (Poct) Market (2026-2031): High Tech Outlook Report - Product Image

2025 Global Forecast for Point-Of-Care (Poc) Testing (Poct) Market (2026-2031): High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.